Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases.
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -3.68 | -5.24515393387 | 70.16 | 70.44 | 63.625 | 875402 | 67.5187972 | CS |
4 | -7.68 | -10.355987055 | 74.16 | 81 | 63.625 | 662238 | 72.89077364 | CS |
12 | -20.54 | -23.6037692484 | 87.02 | 107.3699 | 63.625 | 622632 | 83.33417571 | CS |
26 | 1.62 | 2.49768732655 | 64.86 | 107.3699 | 49 | 534198 | 78.74375444 | CS |
52 | 11.87 | 21.7359457975 | 54.61 | 107.3699 | 47.88 | 497397 | 69.86525452 | CS |
156 | 47.48 | 249.894736842 | 19 | 107.3699 | 6.035 | 482893 | 45.4074069 | CS |
260 | 47.48 | 249.894736842 | 19 | 107.3699 | 6.035 | 482893 | 45.4074069 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales